Persistence After Switching From Adalimumab Biosimilar MSB11022 to Adalimumab Biosimilar GP2017 in Patients With Chronic Inflammatory Rheumatic Diseases
慢性炎症性风湿病患者从阿达木单抗生物类似药 MSB11022 换用阿达木单抗生物类似药 GP2017 后的疗效持续性
期刊:JOURNAL OF PHARMACY TECHNOLOGY
影响因子:1.3
doi:10.1177/87551225241306675
Borrás-Blasco, Joaquín; Valcuende-Rosique, Alejandro; Cornejo, Silvia; Aparicio-Rubio, Celia; Aguilar-Zamora, Marta; Garijo-Bufort, Marta; Arévalo-Ruales, Karla Romelia
